Mary-Jane Elliott co-founded Consilium Strategic Communications in 2013 and is an expert in stakeholder communications for international and domestic healthcare companies. She possesses more than 15 years of experience in the healthcare industry from leading agencies and in-house pharma roles. Prior to founding Consilium, Mary-Jane established and led M:Communications’ successful international healthcare team where she advised public and private companies internationally across all sub-sectors of healthcare and including some of the sector’s leading industry bodies. She has a broad range of experience including advising on a wide range of IPOs, secondary fundraisings, private equity placements, M&A transactions and crisis communications. Mary-Jane worked at the FTSE250 company, PowderJect Pharmaceuticals, where she initially worked in R&D and latterly became a member of the Corporate Communications and Investor Relations team prior to the Company's sale to Chiron for £550M in 2003. As a healthcare specialist, Mary-Jane has a BSc (Hons) in BioMedical Sciences.
< Back to Team